The cardiovascular influence of interleukin-1 beta on the expression of bradykinin B1 and B2 receptors

International Immunopharmacology
A RiadC Tschöpe

Abstract

The cytokine interleukin 1ss (IL-1ss) and the bradykinin receptors 1 (B1R) and 2 (B2R) are known to be upregulated in the ischemic heart. In the present study we investigated whether or not there is a causal link between these entities. Further we investigated whether or not pharmacological inhibition of IL-1ss release affects B1R and B2R regulation as well as left ventricular (LV) function in an in vivo rat model of myocardial infarction (MI). B1R and B2R mRNA levels were determined in cultured rat cardiomyocytes, aortic smooth muscle cells and cardiac fibroblasts (n=6 per group) under basal conditions, and after incubation of IL-1ss (40, 400 and 4000 pg/ml). Also, MI was induced in male Sprague-Dawley rats by ligation of the left descending coronary artery. Rats were treated with the interleukin converting enzyme inhibitor (ICEI) pralnacasan (50 mg/kg/day), or with a placebo. Three weeks after induction of MI, LV function was assessed using a 1.4 Millar TIP-catheter. Cardiac expressions of B1R and B2R mRNA were measured using ribonuclease-protection assays. Under basal conditions, both B1R and B2R were expressed in cardiomyocytes and smooth muscle cells, but not in cardiac fibroblasts. IL-1ss cultivation led only in cardiomyo...Continue Reading

References

Sep 1, 1992·The Journal of Experimental Medicine·D J KesslerG E Sonenshein
Mar 15, 1988·European Journal of Pharmacology·Y FujiwaraH I Yamamura
May 1, 1982·Proceedings of the Society for Experimental Biology and Medicine·I KleinM Gondek
Feb 17, 1999·Journal of Molecular and Cellular Cardiology·N G FrangogiannisM L Entman
Jan 15, 2000·Biochimica Et Biophysica Acta·K YayamaH Okamoto
Jun 14, 2000·European Journal of Pharmacology·S B PhagooG M Burgess
Jul 18, 2006·Current Medicinal Chemistry·Nikolaos G Frangogiannis
Dec 5, 2006·Current Opinion in Nephrology and Hypertension·Alexander RiadCarsten Tschöpe

❮ Previous
Next ❯

Citations

Nov 26, 2010·Biochemical and Biophysical Research Communications·K RichesC Peers
Jan 18, 2011·The Journal of Immunology : Official Journal of the American Association of Immunologists·Alexander RiadCarsten Tschöpe

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiac Remodeling

Cardiac remodeling in response to a myocardial infarction is characterized by progressive ventricular dilatation, cardiac hypertrophy, fibrosis, and deterioration of cardiac performance. Discover the latest research on Cardiac Remodeling here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.